- Q3 2023 Jubilant Pharmova Ltd Earnings Call TranscriptFeb 03, 2023₹343.85 (-1.24%)Earnings
- Q2 2023 Jubilant Pharmova Ltd Earnings Call TranscriptOct 21, 2022₹340.6 (+5.29%)Earnings
- Q1 2023 Jubilant Pharmova Ltd Earnings Call TranscriptAug 02, 2022₹361.05 (-2.81%)Earnings
- Q4 2022 Jubilant Pharmova Ltd Earnings Call TranscriptMay 27, 2022₹404.3 (+1.81%)Earnings
- Q3 2022 Jubilant Pharmova Ltd Earnings Call TranscriptFeb 04, 2022₹526.4 (+0.40%)Earnings
- Q2 2022 Jubilant Pharmova Ltd Earnings Call TranscriptOct 22, 2021₹604.1 (-1.25%)Earnings
- Q1 2022 Jubilant Pharmova Ltd Earnings Call TranscriptJul 23, 2021₹696.9 (-2.59%)Earnings
- Jubilant Pharmova Ltd Investor & Analyst Meet TranscriptJun 18, 2021
- Q3 2021 Jubilant Life Sciences Ltd Earnings Call TranscriptFeb 05, 2021₹935.15 (+2.88%)Earnings
- Q2 2021 Jubilant Life Sciences Ltd Earnings Call TranscriptNov 04, 2020₹528.79 (+1.50%)Earnings
- Q1 2021 Jubilant Life Sciences Ltd Earnings Call TranscriptSep 04, 2020₹620.74 (+1.33%)Earnings
- Q4 2020 Jubilant Life Sciences Ltd Earnings Call TranscriptMay 29, 2020₹330.91 (+1.73%)Earnings
- Jubilant Life Sciences Limited - Special Call TranscriptApr 01, 2020
- Q3 2020 Jubilant Life Sciences Ltd Earnings Call TranscriptJan 31, 2020₹435.44 (-3.55%)Earnings
- Q2 2020 Jubilant Life Sciences Ltd Earnings Call TranscriptOct 25, 2019₹420.03 (-1.45%)Earnings
- Q1 2020 Jubilant Life Sciences Ltd Earnings Call TranscriptJul 26, 2019₹333.61 (-0.22%)Earnings
- Q4 2019 Jubilant Life Sciences Ltd Earnings Call TranscriptMay 17, 2019₹445.99 (-4.09%)Earnings
Q2 2022 Jubilant Pharmova Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Jubilant Pharmova Limited Earnings Conference Call for the quarter and half year ended September 30, 2021. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Vineet Mayer, Head of Investor Relations at Jubilant Pharmova Limited. Thank you, and over to you.
Thank you, Stanford. Good evening, everyone. Thank you for being with us on our Q2 FY '22 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Arvind Chokhany, Group CFO; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Giuliano Perfetti, CEO, Jubilant Biosys; Mr. Syed Kazmi, CEO, Jubilant Therapeutics; and Mr. Arun
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)